These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 25241554)

  • 1. [Uptodate in the management and treatment of ANCA-associated vasculitis].
    Belaconi IN; Toma CL; Bogdan MA
    Pneumologia; 2014; 63(2):78-80, 83-6. PubMed ID: 25241554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis.
    Rich EN; Brown KK
    Curr Opin Pulm Med; 2012 Sep; 18(5):447-54. PubMed ID: 22854508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seven clinical conundrums in the treatment of ANCA-associated vasculitis.
    Alba MA; Flores-Suárez LF
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S74-83. PubMed ID: 23663685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Necrotizing vasculitis--a 2009 update.
    Sharaf PH; Yazici Y
    Bull NYU Hosp Jt Dis; 2009; 67(3):303-5. PubMed ID: 19852754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
    Lally L; Spiera R
    Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-neutrophil cytoplasmic antibody-associated vasculitis. Clinical aspects and treatment].
    Paolini MV; Ruffino JP; Fernández Romero DS
    Medicina (B Aires); 2013; 73(2):119-26. PubMed ID: 23570759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
    Jones RB; Furuta S; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh M; Westman K; Jayne DR;
    Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
    Pagnoux C; Mahr A; Hamidou MA; Boffa JJ; Ruivard M; Ducroix JP; Kyndt X; Lifermann F; Papo T; Lambert M; Le Noach J; Khellaf M; Merrien D; Puéchal X; Vinzio S; Cohen P; Mouthon L; Cordier JF; Guillevin L;
    N Engl J Med; 2008 Dec; 359(26):2790-803. PubMed ID: 19109574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
    Maritati F; Alberici F; Oliva E; Urban ML; Palmisano A; Santarsia F; Andrulli S; Pavone L; Pesci A; Grasselli C; Santi R; Tumiati B; Manenti L; Buzio C; Vaglio A
    PLoS One; 2017; 12(10):e0185880. PubMed ID: 29016646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ANCA-associated vasculitis].
    Holle JU
    Internist (Berl); 2015 Jan; 56(1):41-50; quiz 51-2. PubMed ID: 25502657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of methotrexate in ANCA-associated vasculitides.
    Reinhold-Keller E; de Groot K
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S178-82. PubMed ID: 21044456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current therapies for ANCA-associated vasculitis.
    Lally L; Spiera R
    Annu Rev Med; 2015; 66():227-40. PubMed ID: 25341007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell depleting agents for ANCA vasculitides: a new therapeutic approach.
    Gómez-Puerta JA; Quintana LF; Stone JH; Ramos-Casals M; Bosch X
    Autoimmun Rev; 2012 Jul; 11(9):646-52. PubMed ID: 22146313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L52. Vasculitis treatment: is it time to change the standard of care for ANCA-associated vasculitis?
    Hoffman GS
    Presse Med; 2013 Apr; 42(4 Pt 2):643-50. PubMed ID: 23474045
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of rituximab in the treatment of ANCA-associated vasculitides (AAV).
    Daikeler T; Kistler AD; Martin PY; Vogt B; Huynh-Do U
    Swiss Med Wkly; 2015; 145():w14103. PubMed ID: 25658140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ANCA-associated vasculitis with renal involvement: an outcome analysis.
    Weidner S; Geuss S; Hafezi-Rachti S; Wonka A; Rupprecht HD
    Nephrol Dial Transplant; 2004 Jun; 19(6):1403-11. PubMed ID: 15069175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wegener granulomatosis (granulomatosis with polyangiitis): evolving concepts in treatment.
    Lynch JP; Tazelaar H
    Semin Respir Crit Care Med; 2011 Jun; 32(3):274-97. PubMed ID: 21674414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis].
    Tervaert JW; Stegeman CA
    Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2265-7. PubMed ID: 14655291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating vasculitis with conventional immunosuppressive agents.
    Jayne D
    Cleve Clin J Med; 2012 Nov; 79 Suppl 3():S46-9. PubMed ID: 23203646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of ANCA-associated vasculitides (AAV).
    Holle JU; Gross WL
    Autoimmun Rev; 2013 Feb; 12(4):483-6. PubMed ID: 22921792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.